Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) issued its earnings results on Thursday. The company reported ($0.40) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.46) by $0.06, FiscalAI reports. The company…
Swedbank AB Takes Position in NewAmsterdam Pharma Company N.V. $NAMS
Swedbank AB acquired a new stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 90,900…
GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue
GoodRx (GDRX +2.82%) primarily generates revenue by offering a price comparison tool that helps consumers find geographically relevant pricing and access negotiated discounts on prescription drugs across the United States. While expanding its…
Andhra Pradesh govt.'s move to help local products earn global brand recognition
As part of its efforts to transform the products made in Andhra Pradesh into recognised global brands, the government has initiated steps to develop Product Perfection Clusters (PPCs) in the Amaravati, Visakhapatnam and Tirupati economic regions…
Vanguard Group Inc. Lowers Position in Catalyst Pharmaceuticals, Inc. $CPRX
Vanguard Group Inc. cut its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 3.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,432,247…
Think carefully before getting tested for HIV
Following is an English translation of an article I wrote that was published on Starnieuws yesterday. The original article is in Dutch and you can read it on Starnieuws if you prefer that version. An article on Starnieuws from May 4 describes a…
The Chemours Company $CC Stock Position Boosted by Vanguard Group Inc.
Vanguard Group Inc. boosted its stake in The Chemours Company (NYSE:CC - Free Report) by 2.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,920,868 shares…
The Goldman Sachs Group, Inc. $GS Shares Acquired by NewEdge Wealth LLC
NewEdge Wealth LLC boosted its holdings in The Goldman Sachs Group, Inc. (NYSE:GS - Free Report) by 74.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned…
AbbVie Inc. $ABBV Shares Bought by NewEdge Wealth LLC
NewEdge Wealth LLC grew its holdings in AbbVie Inc. (NYSE:ABBV - Free Report) by 30.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 397,677 shares…
Altman Advisors Inc. Sells 5,338 Shares of AbbVie Inc. $ABBV
Altman Advisors Inc. trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV - Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,536 shares…
15 TV Shows To Watch If You Like Matlock
'Matlock' is one of several current TV shows that are revitalizing the network procedural with snappy writing, world-class acting, and fresh takes on familiar themes. The CBS series stars Kathy Bates as Madeline Matlock (whose legal name is…
Book Review: 3/11 Viral Takeover
Here's a thoughtful review of my book 3/11 Viral Takeover from the Bioregulatory Medicine Institute. There are books that comfort, books that entertain, and books that disturb — in the most necessary way. Sonia Elijah's debut, 3/11: Viral…
Sunday Strip: Rat Catchers Needed:
The alternate headline for this clip is that this is Bobby practicing the skills necessary to survive DC culture as Secretary of Health. Malone News is a reader-supported publication. To receive new posts and support our work, consider becoming a…
Receive a Daily briefing on Pharma Industry News
Get Started